A Phase 1b Randomized, Controlled, Double-Blinded Dosage-Escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age-Reference-Cited by-同舟云学术

A Phase 1b Randomized, Controlled, Double-Blinded Dosage-Escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age

Published:2013-11-11 Issue:11 Volume:8 Page:e78679
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ouédraogo Alphonse,Tiono Alfred B.,Kargougou Désiré,Yaro Jean Baptiste,Ouédraogo Esperance,Kaboré Youssouf,Kangoye David,Bougouma Edith C.,Gansane Adama,Henri Noelie,Diarra Amidou,Sanon Souleymane,Soulama Issiaka,Konate Amadou T.,Watson Nora L.,Brown Valerie,Hendriks Jenny,Pau Maria Grazia,Versteege Isabella,Wiesken Edison,Sadoff Jerald,Nebie Issa,Sirima Sodiomon B.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites;C Cerami;Cell,1992

2. Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes;U Frevert;J Exp Med,1993

3. Structural and functional properties of region II-plus of the malaria circumsporozoite protein;P Sinnis;J Exp Med,1994

4. Cell adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG;SM Gantt;J Biol Chem,1997

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications;Molecular Therapy - Methods & Clinical Development;2024-09

2. Inhaled aerosol viral-vectored vaccines against tuberculosis;Current Opinion in Virology;2024-06

3. Nanotechnology Based Vaccination Approach in Malarial Infection;Infectious Diseases Drug Delivery Systems;2023

4. Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy;Viruses;2022-12-06

5. Seroprevalence of neutralizing antibodies against adenovirus type 26 and 35 in healthy populations from Guangdong and Shandong provinces, China;Virologica Sinica;2022-10